Fatty Acid Nitroalkenes Inhibit the Inflammatory Response to Bleomycin-mediated Lung Injury
Overview
Toxicology
Authors
Affiliations
Fatty acid nitroalkenes are reversibly-reactive electrophiles, endogenously detectable at nM concentrations, displaying anti-inflammatory actions. Nitroalkenes like 9- or 10-nitro-octadec-9-enoic acid (e.g. nitro-oleic acid, OA-NO) pleiotropically suppress cardiovascular inflammatory responses, with pulmonary responses less well defined. C57BL/6 J male mice were intratracheally administered bleomycin (3 U/kg, ITB), to induce pulmonary inflammation and acute injury, or saline and were treated with 50 μL OA-NO (50 μg) or vehicle in the same instillation and 72 h post-exposure to assess anti-inflammatory properties. Bronchoalveolar lavage (BAL) and lung tissue were collected 7d later. ITB mice lost body weight, with OA-NO mitigating this loss (-2.3 ± 0.94 vs -0.4 ± 0.83 g). Histology revealed ITB induced cellular infiltration, proteinaceous debris deposition, and tissue injury, all significantly reduced by OA-NO. Flow cytometry analysis of BAL demonstrated loss of Siglec F/F4/80/CD45 alveolar macrophages with ITB (89 ± 3.5 vs 30 ± 3.7%). Analysis of CD11b/CD11c expressing cells showed ITB-induced non-resident macrophage infiltration (4 ± 2.3 vs 43 ± 2.4%) was decreased by OA-NO (24 ± 2.4%). Additionally, OA-NO attenuated increases in mature, activated interstitial macrophages (23 ± 4.8 vs. 43 ± 5.4%) in lung tissue digests. Flow analysis of CD31/CD45/Sca-1 mesenchymal cells revealed ITB increased CD44 populations (1 ± 0.4 vs 4 ± 0.4MFI), significantly reduced by OA-NO (3 ± 0.4MFI). Single cell analysis of mesenchymal cells by western blotting showed profibrotic ZEB1 protein expression induced by ITB. Lung digest CD45 cells revealed ITB increased HMGB1 cells, with OA-NO suppressing this response. Inhibition of HMGB1 expression correlated with increased basal phospholipid production and SP-B expression in the lung lining. These findings indicate OA-NO inhibits ITB-induced pro-inflammatory responses by modulating resident cell function.
Meshanni J, Stevenson E, Zhang D, Sun R, Ona N, Reagan E Nat Commun. 2025; 16(1):1806.
PMID: 39984450 PMC: 11845678. DOI: 10.1038/s41467-025-56448-y.
Ma H, Gao L, Chang R, Zhai L, Zhao Y Heliyon. 2024; 10(18):e38018.
PMID: 39381218 PMC: 11458987. DOI: 10.1016/j.heliyon.2024.e38018.
Atochina-Vasserman E, Meshanni J, Stevenson E, Zhang D, Sun R, Ona N Res Sq. 2024; .
PMID: 39041040 PMC: 11261981. DOI: 10.21203/rs.3.rs-4656663/v1.
HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage.
Yuan J, Guo L, Ma J, Zhang H, Xiao M, Li N Cell Biol Toxicol. 2024; 40(1):55.
PMID: 39008169 PMC: 11249443. DOI: 10.1007/s10565-024-09893-2.
Stevenson E, Wilkinson M, Abramova E, Guo C, Gow A J Pharmacol Exp Ther. 2022; 382(3):356-365.
PMID: 35970601 PMC: 9426763. DOI: 10.1124/jpet.122.001284.